Browse articles on EyeWorld.org from the Refractive section. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The future of corneal refractive surgery is in the works. EyeWorld checked in on various technologies in the pipeline with physicians in the know.
Among the important indications for use of the EVO ICL (STAAR Surgical)—age, amount of myopia, astigmatism correction, etc.—there is one parameter that some surgeons say could be causing confusion. Five of these surgeons discussed anterior chamber depth.
Refractive Editor Karolinne Rocha, MD, previewed the articles in the section and shared what she is looking forward to at the ASCRS Annual Meeting.
There has been controversy around ICL sizing and vault for a long time, according to some physicians. Three experts discussed the topic in this article.
Creating a true accommodating lens has been a goal for some time in ophthalmology. Several ophthalmologists discussed some of the products currently in development in this space and what makes them unique.
The rotational stability of toric IOLs and reposition rates have been well studied and reported. In most cases, any rotation that occurs postop is usually 5 degrees off axis or less. Four ophthalmologists shared their thoughts on the prevention and management of this issue.
Lens tilt or decentration can occur with intraocular surgery, and while not always something that physicians need to address, this may require attention with more complicated cases or with larger decentrations. A physicist and a physician discussed what they look for and techniques that might be used.
Karolinne Rocha, MD, PhD, considered lessons she has learned and previewed the articles in this issue’s Refractive section.
Many surgeons have now gained experience with the EVO ICL (STAAR Surgical), which was FDA approved in April 2022. Several spoke to EyeWorld about what they’ve learned from using it in practice.
John Marshall, MD, PhD, discusses work being done on laser scleral microporation, a technique that he thinks could “rejuvenate” the eye’s natural dynamically focusing process.
Get the latest ophthalmology news delivered to your inbox every Friday.